Hologic will provide all imaging machinery for Dutch mammography program

Published on:

All mammography systems for the Dutch Breast Cancer Screening Program will be provided by Hologic, Inc. beginning in 2018, according to a recent press release. The multi-year agreement, which has a dual partnership with Tromp Medical, will make sure that Hologic's new 3DimensionsTM mammography systems will be installed in mobile and stationary screening facilities across the Netherlands.  

“Hologic is grateful for the opportunity to extend access to its new, state-of-the-art 3DimensionsTM system to Dutch women starting in 2018,” said Jan Verstreken, Hologic’s regional president for Europe, the Middle East, Africa (EMEA) and Canada, in the press release. “We were proud to learn that during the procurement process, the 3DimensionsTM system was ranked number one in ergonomics and patient comfort by clinicians and screening participants and are hopeful that all Dutch women will take advantage of the invitation to get screened on this system.” 

According to the press release, this agreement is the result of a multifaceted public procurement process conducted by Facilitaire Samenwerking Bevolkingsonderzoeken (FSB) on behalf of the five regional screening organizations responsible for nationwide breast screening in the Netherlands.  

For more information, read the full press release here.  

 
 

 

Related Content

Abbreviated MRI protocols present suitable alternatives for liver cancer screening
Routine abdominal CTs offer insight into cardiovascular risk
Screening efforts have helped avert millions of cancer-related deaths in recent decades
What breast density status can tell us about cardiovascular risk
FDA clears AI tool that flags signs of heart disease in chest CT scans
Patients without PCPs struggle to access lung cancer screening, despite eligibility

Around the web

Radiology Business
AI can help radiology standardize image exam data labeling

To fully leverage today's radiology IT systems, standardization is a necessity. Steve Rankin, chief strategy officer for Enlitic, explains how artificial intelligence can help.

Radiology Business
The biggest obstacles facing radiology business managers in 2025

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.